| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | John Crown | |
| Claire Corcoran | |||
| Lorraine O'Driscoll | |||
| Anne M Friel | |||
| P2860 | cites work | MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer | Q29614237 |
| Intermediate filaments: structure, dynamics, function, and disease | Q29615442 | ||
| Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells | Q30830900 | ||
| Circulating tumor cell analysis: technical and statistical considerations for application to the clinic | Q33559406 | ||
| Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function | Q40327418 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 613-625 | |
| P577 | publication date | 2010-06-15 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer | |
| P478 | volume | 123 |
| Q64246412 | 3D Mammary Epithelial Cell Models: A Goldmine of DCIS Biomarkers and Morphogenetic Mechanisms |
| Q91645137 | A Snapshot of The Tumor Microenvironment in Colorectal Cancer: The Liquid Biopsy |
| Q47250358 | Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles |
| Q26750899 | Cell-free circulating tumor DNA in cancer |
| Q48653724 | Circulating Exosomes in Cardiovascular Diseases |
| Q37942081 | Exosome/microvesicle-mediated epigenetic reprogramming of cells |
| Q38541161 | Exosomes Derived from Breast Cancer Cells, Small Trojan Horses? |
| Q37729108 | Exosomes: From Garbage Bins to Promising Therapeutic Targets. |
| Q26796590 | Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients |
| Q100426632 | Extracellular Vesicles in Cancer Detection: Hopes and Hypes |
| Q26866043 | Extracellular microRNAs in urologic malignancies: chances and challenges |
| Q38064326 | Extracellular vesicles as an emerging mechanism of cell-to-cell communication |
| Q38707369 | Extracellular vesicles in breast cancer drug resistance and their clinical application |
| Q37548836 | Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma. |
| Q38056383 | Hide and seek: tell-tale signs of breast cancer lurking in the blood. |
| Q36259857 | High LIN28A Expressing Ovarian Cancer Cells Secrete Exosomes That Induce Invasion and Migration in HEK293 Cells |
| Q37993698 | Lipid-based carriers of microRNAs and intercellular communication |
| Q34389651 | Mast cell exosomes promote lung adenocarcinoma cell proliferation - role of KIT-stem cell factor signaling |
| Q57799472 | Mastocytosis-derived extracellular vesicles exhibit a mast cell signature, transfer KIT to stellate cells, and promote their activation |
| Q36167322 | MicroRNA Regulation of Cholesterol Metabolism |
| Q37607048 | Molecular characterization of exosome-like vesicles from breast cancer cells. |
| Q58614572 | Molecular prescreening to select patient population in early clinical trials |
| Q38662712 | Review: circulating tumor cells in the practice of breast cancer oncology. |
| Q85706341 | Screening for pancreatic cancer |
| Q33959412 | Screening for pancreatic cancer: why, how, and who? |
| Q26865458 | The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment |
| Q91983543 | Tumor-derived exosomes (TDEs): How to avoid the sting in the tail |
| Q90549471 | Tumor-derived exosomes in cancer metastasis risk diagnosis and metastasis therapy |
| Q34524533 | miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer. |
| Q55002965 | miR-758-3p: a blood-based biomarker that's influence on the expression of CERP/ABCA1 may contribute to the progression of obesity to metabolic syndrome. |
Search more.